Dudediligence.

BioVie Inc

BIVINASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$4.2MSep ’24−$7.1MDec ’24−$2.8MMar ’25−$3.5MJun ’25−$5.1MSep ’25−$6.1MDec ’25−$5.3MMar ’26−$5.6MJun ’26
Fiscal years, by the month each ended
LineJun 2022Jun 2023Jun 2024Jun 2025Jun 2026
Operating income−$27.3M−$45.1M−$32.2M−$18.1M−$22.7M
Net income−$26.1M−$50.3M−$32.1M−$17.5M−$22.1M
Operating cash flow−$19.0M−$40.3M−$27.9M−$19.0M−$19.0M
Cash$18.6M$19.5M$23.8M$17.5M$9.0M
Shares outstanding25.0M3.6M619.0K1.9M7.5M